CN102188560A - Traditional Chinese medicine for treating hyperlipidemia - Google Patents
Traditional Chinese medicine for treating hyperlipidemia Download PDFInfo
- Publication number
- CN102188560A CN102188560A CN2010101190274A CN201010119027A CN102188560A CN 102188560 A CN102188560 A CN 102188560A CN 2010101190274 A CN2010101190274 A CN 2010101190274A CN 201010119027 A CN201010119027 A CN 201010119027A CN 102188560 A CN102188560 A CN 102188560A
- Authority
- CN
- China
- Prior art keywords
- radix
- hyperlipidemia
- treatment
- medicine
- chinese herbs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating hyperlipidemia. The components of the medicine comprise ginseng, Radix Astragali, prepared rehmannia root, fleece-flower root, bighead atractylodes rhizome, rhizoma atractylodis, Poria cocos, Alisma Orientalis, Cortex moutan, radix paeoniae rubrathe, red sage root, rheum officinale, pseudo-ginseng, haw and cassia seed. The selection of medicine components and drugs dose is determined in dependence on the physique and condition of a patient, such as adding rehmanniae radix and ligustrum lucidum for patients of yin asthenia constitution and adding Aconite Root, and cassia twig for patients of yang-deficiency constitution, using decoction or pill. The traditional Chinese medicine treating hyperlipidemia in the invention has the efficacy of supplementing qi, nourishing yin, nourishing kidney, invigorating spleen, disinhibiting dampness, transforming turbidity (reducing phlegm), promoting blood circulation and removing blood stasis, and is suitable for treating hyperlipidemia. The medicine has the advantages of fast effect, no rebound after treatment, prevention of complications caused by hyperlipidemia and no side-effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of hyperlipidemia, belong to Chinese medicine medicine technical field.
Background technology
Hyperlipidemia be a kind of many by yin and yang imbalance, the deficiency of vital energy is not enough so that dysfunction of the spleen in transportation, the expectorant stasis of blood are mingled with caused disease.The clinical drinking and eating irregularly that mostly occurs lacks due to the suitable sports.Along with the raising of people's living standard, variation has taken place in dietary structure, and food rich in fat is included in too much, and activity reduces, so that the hyperlipidemia patient increases, and the disease that is caused by hyperlipidemia also increases, and has seriously influenced the healthy of people.Medical science does not have specific medicament to the treatment hyperlipidemia at present, cures the symptoms, not the disease, and consequently a lot of patients are for a long time ill does not heal, and causes very big Physiological Psychology pressure to the patient, causes very big funds expenditure to family and country.
Summary of the invention
In order to solve the prior art deficiency, satisfy the demand of people to the treatment high blood cholesterol drug, the object of the present invention is to provide a kind of treatment hyperlipidemia effective and can cure, the Chinese medicine that does not rebound after healing.
In order to realize the foregoing invention purpose, the present invention is achieved through the following technical solutions:
The treatment by Chinese herbs hyperlipidemia is characterized in that consisting of of medicine: Radix Ginseng, the Radix Astragali, Radix Rehmanniae Preparata, Radix Polygoni Multiflori, the Rhizoma Atractylodis Macrocephalae, Rhizoma Atractylodis, Poria, Rhizoma Alismatis, Cortex Moutan, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, Radix Notoginseng, Fructus Crataegi, Semen Cassiae.
The treatment by Chinese herbs hyperlipidemia is characterized in that comprising:
(1), the medication and the dosage of above treatment by Chinese herbs hyperlipidemia, formulate according to patient's physical strength, state of an illness weight; Add the Radix Rehmanniae, Fructus Ligustri Lucidi as the inclined to one side deficiency of YIN body constitution of patient, add Radix Aconiti Lateralis Preparata, Ramulus Cinnamomi as the inclined to one side yang deficiency body constitution of patient;
(2), above treatment by Chinese herbs hyperlipidemia dosage form adopts decoction or diffusing, pill;
(3), above treatment by Chinese herbs hyperlipidemia dosage form is as adopting decoction, in order to improve lipid-lowering effect, Radix Notoginseng grinds to the powder in addition, does not go into to decoct.
Medicament selection Radix Ginseng of the present invention, the Radix Astragali, Radix Rehmanniae Preparata, Radix Polygoni Multiflori, the Rhizoma Atractylodis Macrocephalae, Rhizoma Atractylodis, Poria, Rhizoma Alismatis, Cortex Moutan, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, Radix Notoginseng, Fructus Crataegi, Semen Cassiae make up, make each efficacy of drugs produce synergism these drug regimens, thereby can effectively treat hyperlipidemia.Wherein Radix Ginseng, the Radix Astragali, Radix Rehmanniae Preparata, the nourishing kidney of Radix Polygoni Multiflori supplementing QI and nourishing YIN; The Rhizoma Atractylodis Macrocephalae, Rhizoma Atractylodis, Poria, Rhizoma Alismatis invigorating spleen to remove dampnessization turbid (reducing phlegm); Cortex Moutan, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, Radix Notoginseng, mountain are looked into, the blood fat reducing of Semen Cassiae blood circulation promoting and blood stasis dispelling.Wherein Radix Ginseng, the Radix Astragali, Radix Rehmanniae Preparata, Radix Polygoni Multiflori, the Rhizoma Atractylodis Macrocephalae, Rhizoma Atractylodis, Poria are set upright blood lipid regulation; Rhizoma Alismatis, Cortex Moutan, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, Radix Notoginseng, Fructus Crataegi, the eliminating evil blood fat reducingization of Semen Cassiae are turbid, have eliminating evilly just do not hindering, the effect for the treatment of both the principal and secondary aspects of a disease.
The invention has the beneficial effects as follows: Chinese medicine of the present invention is pure natural medical, have rapid-action, cure rate is high, the advantage that has no side effect.General hyperlipemic patients is taken the two weeks fruit that promptly takes effect, and recovers normal two to March, suitably again after more consolidates medication, hyperlipidemia more after no longer bounce-back, and can prevent the caused complication of hyperlipidemia.
The specific embodiment
Below come the present invention is done concrete being described below by specific embodiment:
Get Radix Ginseng, the Radix Astragali, Radix Rehmanniae Preparata, Radix Polygoni Multiflori, the Rhizoma Atractylodis Macrocephalae, Rhizoma Atractylodis, Poria, Rhizoma Alismatis, Cortex Moutan, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, Radix Notoginseng, Fructus Crataegi, Semen Cassiae, according to patient's body constitution difference, state of an illness weight is formulated its medication and dosage, add the Radix Rehmanniae, Fructus Ligustri Lucidi as the inclined to one side deficiency of YIN body constitution of patient, add Radix Aconiti Lateralis Preparata, Ramulus Cinnamomi as the inclined to one side yang deficiency body constitution of patient, merge then and use.
The treatment by Chinese herbs hyperlipidemia adopts three class dosage forms, adopts according to the state of an illness:
(1), decoction: the Chinese medicine that will treat hyperlipidemia is decocted in water for oral dose, and after meal respectively once, Radix Notoginseng grinds to the powder in addition sooner or later, does not go into to decoct warm boiled water;
(2), powder: after the Chinese medicine that will treat hyperlipidemia is equipped with dry grinding respectively, merges and use;
(3), pill: after the Chinese medicine that will treat hyperlipidemia is equipped with dry grinding respectively, adds water pill and use.
Decoction: generally be suitable for the hyperlipemic patients begin treatment; Powder and pill: the consolidation and the prophylactic treatment that generally are applicable to hyperlipemic patients.
A kind of Chinese medicine for the treatment of hyperlipidemia of the present invention has the effect of supplementing QI and nourishing YIN nourishing kidney, invigorating spleen to remove dampnessization turbid (reducing phlegm), blood circulation promoting and blood stasis dispelling blood fat reducing, instructions of taking, a twice-daily, one after each meal according to quantity, to treatment, prevention hyperlipidemia, the caused complication of prevention hyperlipidemia all has extraordinary curative effect.
Below announce the present invention as above with preferred embodiment, all employings are equal to the technical scheme that mode obtained of replacement or equivalent transformation, all drop in protection scope of the present invention.
Claims (5)
1. treatment by Chinese herbs hyperlipidemia, its medicine consists of: Radix Ginseng, the Radix Astragali, Radix Rehmanniae Preparata, Radix Polygoni Multiflori, the Rhizoma Atractylodis Macrocephalae, Rhizoma Atractylodis, Poria, Rhizoma Alismatis, Cortex Moutan, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, Radix Notoginseng, Fructus Crataegi, Semen Cassiae.
2. the medication and the dosage of the described treatment by Chinese herbs hyperlipidemia of claim 1 are formulated according to patient's physical strength, state of an illness weight, add the Radix Rehmanniae, Fructus Ligustri Lucidi as the inclined to one side deficiency of YIN body constitution of patient, add Radix Aconiti Lateralis Preparata, Ramulus Cinnamomi as the inclined to one side yang deficiency body constitution of patient.
3. the dosage form of the described treatment by Chinese herbs hyperlipidemia of claim 1 adopts decoction or diffusing, pill.
4. the described treatment by Chinese herbs hyperlipidemia of claim 1 is as adopting decoction, and in order to improve lipid-lowering effect, Radix Notoginseng porphyrize does not in addition go into to decoct.
5. the described treatment by Chinese herbs hyperlipidemia of claim 1, if take treatment hyperlipidemia medicine blood fat recovered normal after, take treatment hyperlipidemia medicine again, can play the after treatment effect, the bounce-back of prevention hyperlipidemia, the complication that the prevention hyperlipidemia causes, its dosage and medication number of times can suitably reduce.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101190274A CN102188560A (en) | 2010-03-08 | 2010-03-08 | Traditional Chinese medicine for treating hyperlipidemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101190274A CN102188560A (en) | 2010-03-08 | 2010-03-08 | Traditional Chinese medicine for treating hyperlipidemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102188560A true CN102188560A (en) | 2011-09-21 |
Family
ID=44597995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101190274A Pending CN102188560A (en) | 2010-03-08 | 2010-03-08 | Traditional Chinese medicine for treating hyperlipidemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102188560A (en) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102343023A (en) * | 2011-10-18 | 2012-02-08 | 泽中卡 | Medicinal composition and preparation method and application thereof |
| CN102526639A (en) * | 2012-03-13 | 2012-07-04 | 常熟华港制药有限公司 | Chinese medicinal composition for treating hyperlipidemia and preparation method thereof |
| CN102727764A (en) * | 2012-05-31 | 2012-10-17 | 固镇县中医院 | Traditional Chinese medicine for treating blood-heat type thrombocytopenia |
| CN103055028A (en) * | 2013-01-29 | 2013-04-24 | 浙江中医药大学 | Medicine for treating early microangiopathy of diabetes mellitus and preparation method thereof |
| CN103083582A (en) * | 2013-02-05 | 2013-05-08 | 孟宪兰 | Medicine for treating hyperlipidemia |
| CN103735939A (en) * | 2013-12-30 | 2014-04-23 | 广西梧州制药（集团）股份有限公司 | Lipid-lowering Chinese medicinal composition and preparation method thereof |
| CN104107244A (en) * | 2014-03-05 | 2014-10-22 | 王悦阳 | Lipid regulation and pulse-beat invigoration pill |
| CN104208302A (en) * | 2014-08-26 | 2014-12-17 | 青岛恒波仪器有限公司 | Fructus rosae laevigatae healthy oral solution for reducing blood fat and preparation method thereof |
| CN104288412A (en) * | 2014-11-07 | 2015-01-21 | 河南中医学院 | Traditional Chinese medicinal composition for treating metabolic syndrome |
| CN105832925A (en) * | 2016-05-17 | 2016-08-10 | 李晓维 | Traditional Chinese medicine composition for treating hyperlipidaemia |
| CN105853626A (en) * | 2016-05-24 | 2016-08-17 | 内蒙古中安类风湿骨关节病专科医院有限责任公司 | Traditional Chinese medicine composition for treating fatty liver and hyperlipidemia |
| CN106109817A (en) * | 2016-09-14 | 2016-11-16 | 吕迎丽 | The Chinese medicine composition for the treatment of hyperlipidemia |
| CN106421473A (en) * | 2016-11-07 | 2017-02-22 | 成都泠汐尚品科技有限公司 | Preparation method of traditional Chinese medicine capable of reducing blood lipid |
| US10548940B2 (en) | 2014-05-12 | 2020-02-04 | Beijing Hebabiz Biotechnology Co., Inc. | Pharmaceutical composition for controlling blood lipids and body weight, and use thereof |
-
2010
- 2010-03-08 CN CN2010101190274A patent/CN102188560A/en active Pending
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102343023B (en) * | 2011-10-18 | 2013-04-10 | 泽中卡 | Medicinal composition and preparation method and application thereof |
| CN102343023A (en) * | 2011-10-18 | 2012-02-08 | 泽中卡 | Medicinal composition and preparation method and application thereof |
| CN102526639B (en) * | 2012-03-13 | 2013-09-11 | 常熟华港制药有限公司 | Chinese medicinal composition for treating hyperlipidemia and preparation method thereof |
| CN102526639A (en) * | 2012-03-13 | 2012-07-04 | 常熟华港制药有限公司 | Chinese medicinal composition for treating hyperlipidemia and preparation method thereof |
| CN102727764A (en) * | 2012-05-31 | 2012-10-17 | 固镇县中医院 | Traditional Chinese medicine for treating blood-heat type thrombocytopenia |
| CN103055028A (en) * | 2013-01-29 | 2013-04-24 | 浙江中医药大学 | Medicine for treating early microangiopathy of diabetes mellitus and preparation method thereof |
| CN103083582B (en) * | 2013-02-05 | 2014-05-28 | 孟宪兰 | Medicine for treating hyperlipidemia |
| CN103083582A (en) * | 2013-02-05 | 2013-05-08 | 孟宪兰 | Medicine for treating hyperlipidemia |
| CN103735939A (en) * | 2013-12-30 | 2014-04-23 | 广西梧州制药（集团）股份有限公司 | Lipid-lowering Chinese medicinal composition and preparation method thereof |
| CN104107244A (en) * | 2014-03-05 | 2014-10-22 | 王悦阳 | Lipid regulation and pulse-beat invigoration pill |
| US10548940B2 (en) | 2014-05-12 | 2020-02-04 | Beijing Hebabiz Biotechnology Co., Inc. | Pharmaceutical composition for controlling blood lipids and body weight, and use thereof |
| CN104208302A (en) * | 2014-08-26 | 2014-12-17 | 青岛恒波仪器有限公司 | Fructus rosae laevigatae healthy oral solution for reducing blood fat and preparation method thereof |
| CN104288412A (en) * | 2014-11-07 | 2015-01-21 | 河南中医学院 | Traditional Chinese medicinal composition for treating metabolic syndrome |
| CN104288412B (en) * | 2014-11-07 | 2018-04-20 | 河南中医药大学 | A kind of Chinese medicine composition for treating metabolic syndrome |
| CN105832925A (en) * | 2016-05-17 | 2016-08-10 | 李晓维 | Traditional Chinese medicine composition for treating hyperlipidaemia |
| CN105853626A (en) * | 2016-05-24 | 2016-08-17 | 内蒙古中安类风湿骨关节病专科医院有限责任公司 | Traditional Chinese medicine composition for treating fatty liver and hyperlipidemia |
| CN106109817A (en) * | 2016-09-14 | 2016-11-16 | 吕迎丽 | The Chinese medicine composition for the treatment of hyperlipidemia |
| CN106421473A (en) * | 2016-11-07 | 2017-02-22 | 成都泠汐尚品科技有限公司 | Preparation method of traditional Chinese medicine capable of reducing blood lipid |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102188560A (en) | Traditional Chinese medicine for treating hyperlipidemia | |
| CN103463404B (en) | Traditional Chinese medicine composition for treating liver and kidney yin deficiency | |
| CN102319407B (en) | Traditional Chinese medicine for treating gastroptosis and extraction method thereof | |
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN102652779A (en) | Traditional Chinese medicine particle for treating refractory heart failure and preparation method thereof | |
| CN101683503A (en) | Traditional Chinese medicine composition for nourishing heart and strengthening heart | |
| CN101062368A (en) | Chinese traditional medicine for treating cirrhosis ascites | |
| CN103301426A (en) | Capsule for invigorating circulation and benefiting heart | |
| CN104001035A (en) | Trichosanthis Radix and Radix Puerariae-containing traditional Chinese medicinal preparation for treating type 2 diabetes mellitus | |
| CN101987138A (en) | Chinese medicinal preparation for treating impotence | |
| CN102406834A (en) | Medicament for treating Yang deficiency of women menopause syndrome | |
| CN102988616B (en) | Chinese medicinal composition for treating anemia | |
| CN101912524B (en) | Schisandra liver-benefiting capsules | |
| CN103142920A (en) | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof | |
| CN102327572A (en) | Chinese medicament for invigorating primordial energy and treating gastroptosis and extraction method thereof | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN101991747A (en) | Chinese material medical preparation for treating hepatitis B and ascitesduetocirrhosis | |
| CN101491612B (en) | Medicine for treating mammary hyperplasia and early breast cancer | |
| CN103028076B (en) | Traditional Chinese medicine composition for treating liver cirrhosis | |
| CN102397438A (en) | Medicine for treating low renal function | |
| CN103169855A (en) | Drug composition for treating chronic heart failure | |
| CN102652800A (en) | Traditional Chinese medicine (TCM) prescription for treating nervous insomnia | |
| CN101683446A (en) | Traditional Chinese medicine composition with function of invigorating circulation and reducing blood fat | |
| CN105126022A (en) | Medicine for treating ichthyosis and preparation method of medicine | |
| CN1562229A (en) | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhang Xilin Document name: Notification of before Expiration of Request of Examination as to Substance |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110921 |